Video

Giuliana Rancic: Finding the Light at the End of the Tunnel

Entertainment journalist and breast cancer survivor Giuliana Rancic shared her cancer journey before she presented at the 2019 Extraordinary Healer Award for Oncology Nursing.

Best known for her work on E! News, Giuliana Rancic revealed her ability to find the light at the end of the tunnel following her breast cancer journey.

Before the 2019 Extraordinary Healer Award for Oncology Nursing, Rancic shared on her cancer journey, assuring other women that they are not alone. “Something that helped me were the four words, ‘This too, shall pass’. With every little tough moment I was having, I would keep falling back on that. Just knowing that it’s going to get better, knowing that it’s OK to feel scared, it’s OK to be sad, it’s OK to wake up in the middle of the night and be terrified. It’s so normal and so many people feel the way you do.”

Cancer-free for seven years, she also discussed the hardest years of her journey with breast cancer. “It was very hard for me to feel like I could go back to a life without thinking about breast cancer 100 times a day,” Rancic said. “And I’m living proof that it can happen.”

Related Videos
Image of Dr. Goy.
Dr. Tycel Phillips is an Associate Professor in the Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, at City of Hope in Duarte, California.
Image of Dr. Salani.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Suneel Kamath is an assistant professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, in Ohio.
Image of Dr. Fakih.
Dr. Catherine Wu is chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston, Massachusetts.
Dr. John Oertle discusses the key benefits to come from patients with cancer connecting with support networks, advocacy groups and resources.
Dr. Gabriel A. Brooks discussed the recent FDA product labeling update for Xeloda and 5-FU.
Dr. Alan Tan is the GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer with the Alliance for Clinical Trials in Oncology.